comparemela.com

Latest Breaking News On - Archana jain - Page 7 : comparemela.com

PR Pundit unveils 'Alchemy': Challenge for young PR practitioner

The Alchemy case study challenge supported by Comms News, Reputation Today and PRovoke Media, will have three winner duos who will get an opportunity to be felicitated at PRAXIS 2023 in Chennai sponsored by the organising committee and the front rank

India
Chennai
Tamil-nadu
Archana-jain
Comms-news
Reputation-today
Managing-director

Commander Shangpliang announces the Meghalaya International Film Festival

Commander Shangpliang announces the Meghalaya International Film Festival
laosnews.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from laosnews.net Daily Mail and Mail on Sunday newspapers.

India
Mumbai
Maharashtra
Ekta-jain
Yogesh-lakhani
Manav-sohal
Harvider-singh
Harjeet-singh-anand
Salman-khan
Shravani-goswami
Mohan-rathod
Pankaj-berry

Blindwink unveils the Awardees of the 5th Edition Of India Design Awards 2023

New Delhi, April 24: recently hosted the 5th Edition Of, a ceremony dedicated to recognizing and celebrating the creative achievements of Architects and Interior Designers across India. Amrita Rao, a Bollywood celebrity, and Krishna Rao Jiasim, an Architect, were the esteemed guests of honour.

Raipur
Chhattisgarh
India
Chennai
Tamil-nadu
Sudan
Pune
Maharashtra
Hyderabad
Andhra-pradesh
Nadiad
Gujarat

Bugworks Research Inc. to Present Eight Posters at the 33rd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) 2023, in Copenhagen, Denmark

BANGALORE, India and DELAWARE CITY, Del. and ADELAIDE, Australia, April 17, 2023 /PRNewswire/ Bugworks Research Inc., a clinical-stage biopharmaceutical company, is set to present its latest research findings on the novel bacterial topoisomerase inhibitor, BWC0977 at the upcoming 33rd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Copenhagen, Denmark. The eight posters highlight data from the microbiological and efficacy studies of the clinical candidate, BWC0977 that exhibits broad-spectrum activity against a globally, diverse panel of Gram-positive, Gram-negative and biothreat pathogens. Additionally, data from a range of studies, including in vitro biochemical assays, in vitro resistance frequency studies, minimum inhibitory concentration (MIC90) data against multi-drug resistant clinical isolates from around the world, and in vivo efficacy data in mice and rat models of infection will be presented. These studies were conducted in collaboration wi

Adelaide
South-australia
Australia
Delaware
United-states
Copenhagen
Køavn
Denmark
United-kingdom
Bangalore
Karnataka
India

vimarsana © 2020. All Rights Reserved.